Clinical trials
COVID-19 Infection clinical trials
Below are recruiting covid-19 infection clinical trials, each written for real people, not researchers. We’re tracking 175 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06311435Recruiting
Blood test for long COVID diagnosis
This study is testing a new blood test that looks for specific RNA markers to help diagnose long COVID. If you have new, lasting symptoms after a confirmed COVID-19 infection, this study may help find answers.
Iowa City, IowaAges 18 years+ - NCT06355258RecruitingPhase 1
Troxerutin to prevent blood clots in COVID-19 patients
This trial tests if the drug troxerutin can prevent dangerous blood clots in adults hospitalized with mild or severe COVID-19. If you have COVID-19 and are not already on blood thinners or at high risk for bleeding, you may be able to join.
Shaoxing, ZhejiangAges 18 years+ - NCT07108036RecruitingPhase 2
Testing Anktiva for Long COVID Symptoms
This trial tests a medicine called Anktiva to see if it can help people with Long COVID. It's for adults who had a confirmed COVID-19 infection and now have lasting symptoms like fatigue, brain fog, or trouble breathing.
San Francisco, CaliforniaAges 18–70 - NCT06511063RecruitingPhase 2
Antiviral trial for treating long covid symptoms
This study tests whether antiviral drugs (Truvada and Selzentry) can help people with long COVID. You may qualify if you have had long COVID symptoms for at least 6 months, including fatigue and post-exertional malaise.
New York, New YorkAges 18 years+ - NCT06142253Recruiting
Water exercise for long COVID brain fog
This study tests whether water-based exercise (like swimming or water aerobics) helps veterans recover from long COVID, especially brain fog and memory problems. If you're a veteran with ongoing thinking issues after COVID-19, this may help you improve your symptoms over 8 months.
Palo Alto, CaliforniaAges 18–89 - NCT06633666Recruiting
Acupuncture for Long COVID brain and mood symptoms
This study tests whether acupuncture can help with brain fog, memory problems, depression, or anxiety that started after COVID-19 and won't go away. If you have Long COVID and these symptoms, acupuncture might offer relief.
Kowloon Tong, KowloonAges 18–80 - NCT06928116Recruiting
Heat therapy and exercise for COVID-19 recovery
This study tests whether heat therapy (using warm temperatures) combined with a leg exercise program can help improve fatigue and physical function in people who have had COVID-19 and still feel symptoms like tiredness or reduced mobility.
Omaha, NebraskaAges 50–90 - NCT05188612Recruiting
Hospital patients with confirmed COVID-19 survey study
This study collects information from adults who are in the hospital for confirmed COVID-19. The goal is to better understand what happens during acute (early) COVID-19 and improve care.
Bologna, BolognaAges 18 years+ - NCT06577467Recruiting
Studying leftover virus after covid recovery
This study looks for signs of leftover SARS-CoV-2 virus in people who have fully recovered from COVID-19, including those with ongoing neurological symptoms (like brain fog, fatigue, or nerve pain). It aims to understand why some people have long-lasting symptoms after infection.
Bethesda, MarylandAges 18–110 - NCT07189936RecruitingPhase 2
Testing 2-HOBA for Immune Issues in Long COVID with POTS
This trial tests if a medication called 2-HOBA can help with ongoing immune system issues in people with Long COVID who also have POTS. It aims to reduce fatigue and other symptoms by calming overactive immune responses.
Nashville, TennesseeAges 18 years+ - NCT04858412Recruiting
Amino acid supplement to help people with COVID-19 and alcohol liver disease
This study tests whether an HMB-enriched amino acid supplement can improve outcomes in adults who have COVID-19 pneumonia, especially those with alcohol-related liver disease. The trial compares results in people with alcohol liver disease versus those without, to see if the supplement helps during recovery.
Cleveland, OhioAges 21 years+ - NCT04978571Recruiting
Electrical nerve stimulation for long-lasting concussion symptoms
This study tests whether a device that delivers gentle electrical signals to nerves through the skin can help children and teens with concussion symptoms that have lasted at least 3 months. You may be asked to attend clinic visits for the nerve stimulation setup if you meet the safety and scheduling requirements.
Orange, CaliforniaAges 11–18 - NCT05858502Recruiting
Study immune response to COVID-19 and improve testing
This study looks at how the immune system in the body responds to different COVID-19 virus variants. It may help improve how COVID-19 is diagnosed by comparing people who are currently infected and those who are not.
ParisAges 18–65 - NCT06417762Recruiting
A study testing social media health messages for community health workers
This trial teaches community health workers how to find and share true health information on social media, and how to spot and stop false information. It aims to reduce illness from respiratory viruses in seven communities.
Chicago, IllinoisAges 18–99 - NCT07417176Recruiting
Persistent COVID-19 registry study in Navarre
This study is a registry for people in Navarre, Spain, who have long-lasting COVID-19 symptoms (more than 3 months). By joining, you help doctors learn more about persistent COVID and how to care for it.
Pamplona, NavarreAges Any age - NCT06590324RecruitingPhase 2/Phase 3
Study of Apabetalone for long COVID
This trial tests an experimental drug called Apabetalone for people with long COVID. You may be eligible if you have type 2 diabetes, take or are willing to take dapagliflozin, and have had long COVID symptoms for at least 2 months after your COVID infection.
AmmanAges 18 years+ - NCT06716996Recruiting
Brain stimulation for mood problems after COVID-19
This study tests if repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation technique, can help people aged 18 to 65 who have ongoing depression or low mood for more than 12 weeks after a confirmed COVID-19 infection. The treatment uses magnetic pulses to gently stimulate parts of the brain involved in mood regulation.
Zurich, Canton of ZurichAges 18–65 - NCT07074158Enrolling by invitation
Looking for long COVID clues in blood
This study compares the blood of people with ongoing long COVID symptoms to healthy people, to look for differences in immune signals and gut bacteria. It could help find better ways to diagnose or treat long COVID.
Palo Alto, CaliforniaAges 18 years+ - NCT01306084Recruiting
Study of viral infections in healthy and immune-compromised people
This trial studies how viruses affect the body, and how the immune system responds, in both healthy people and people with weakened immunity. It may include people who currently have a suspected or recent viral infection, close contacts, people around the time of a viral vaccine, and healthy adults used for comparison.
Bethesda, MarylandAges 6 months–120 years - NCT06012552RecruitingPhase 2
Tianeptine for COVID-19 brain fog
This study tests whether the medication tianeptine can improve brain fog and thinking problems that persist after COVID-19. It may help if you are 18 or older, have had COVID-19, and have noticed new memory or concentration issues.
WarsawAges 18 years+ - NCT04459689Recruiting
COVID-19 study for people with primary immune deficiencies
This study looks at COVID-19 experiences in people who have a primary immune deficiency (a long-term immune problem) and who have had COVID-19. It may help researchers better understand how COVID-19 affects people with these conditions.
ParisAges birth+ - NCT05973084Recruiting
COVID spread study in Malawi households and vaccine recipients
This study tracks how COVID-19 spreads and causes illness in real households in Blantyre, Malawi, and compares groups after infection or vaccination. If you qualify, you’ll do follow-up testing and visits for several months.
Boston, MassachusettsAges 5–75 - NCT07400848Recruiting
Symptoms and recovery after COVID-19 vaccine
This study looks at people who developed new, long-lasting symptoms after a COVID-19 vaccine. It aims to understand their symptoms, do lab tests, and see how they recover over time.
BernAges 18 years+ - NCT07356570Recruiting
Post-COVID care tracking study for long-term symptoms
This study follows people with lasting or complex COVID-19 symptoms who are already in a specialized care program. It aims to better understand and improve recovery after COVID.
Pierre-BéniteAges 18 years+
Hear when a new COVID-19 Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for covid-19 infection?
- Yes. Clin2 currently lists 175 recruiting covid-19 infection studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a covid-19 infection trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a covid-19 infection trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.